BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11070080)

  • 1. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.
    Kobet E; Zeng X; Zhu Y; Keller D; Lu H
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12547-52. PubMed ID: 11070080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.
    Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H
    J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
    Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
    EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
    Knights CD; Liu Y; Appella E; Kulesz-Martin M
    J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.
    Ito A; Lai CH; Zhao X; Saito S; Hamilton MH; Appella E; Yao TP
    EMBO J; 2001 Mar; 20(6):1331-40. PubMed ID: 11250899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
    Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
    J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
    Thomas MC; Chiang CM
    Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.
    Goel A; Janknecht R
    Mol Cell Biol; 2003 Sep; 23(17):6243-54. PubMed ID: 12917345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p53 degradation by Mdm2 acetylation.
    Wang X; Taplick J; Geva N; Oren M
    FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TPR motif cofactor contributes to p300 activity in the p53 response.
    Demonacos C; Krstic-Demonacos M; La Thangue NB
    Mol Cell; 2001 Jul; 8(1):71-84. PubMed ID: 11511361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.
    Espinosa JM; Emerson BM
    Mol Cell; 2001 Jul; 8(1):57-69. PubMed ID: 11511360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
    Liu L; Scolnick DM; Trievel RC; Zhang HB; Marmorstein R; Halazonetis TD; Berger SL
    Mol Cell Biol; 1999 Feb; 19(2):1202-9. PubMed ID: 9891054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 suppresses p73 function without promoting p73 degradation.
    Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H
    Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
    Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
    EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity.
    Bordoli L; Hüsser S; Lüthi U; Netsch M; Osmani H; Eckner R
    Nucleic Acids Res; 2001 Nov; 29(21):4462-71. PubMed ID: 11691934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage activates p53 through a phosphorylation-acetylation cascade.
    Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
    Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.
    Nguyen DX; Baglia LA; Huang SM; Baker CM; McCance DJ
    EMBO J; 2004 Apr; 23(7):1609-18. PubMed ID: 15044952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53.
    Wang Q; Yang Y; Wang L; Zhang PZ; Yu L
    Biochem Biophys Res Commun; 2008 Sep; 374(3):437-41. PubMed ID: 18638452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.
    Barlev NA; Liu L; Chehab NH; Mansfield K; Harris KG; Halazonetis TD; Berger SL
    Mol Cell; 2001 Dec; 8(6):1243-54. PubMed ID: 11779500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.